AllianceBernstein’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-7,442
| Closed | -$64K | – | 3292 |
|
2025
Q1 | $64K | Hold |
7,442
| – | – | ﹤0.01% | 3109 |
|
2024
Q4 | $266K | Hold |
7,442
| – | – | ﹤0.01% | 2933 |
|
2024
Q3 | $352K | Hold |
7,442
| – | – | ﹤0.01% | 2836 |
|
2024
Q2 | $374K | Buy |
7,442
+690
| +10% | +$34.7K | ﹤0.01% | 2828 |
|
2024
Q1 | $756K | Buy |
6,752
+2,025
| +43% | +$227K | ﹤0.01% | 2404 |
|
2023
Q4 | $274K | Sell |
4,727
-503
| -10% | -$29.2K | ﹤0.01% | 2879 |
|
2023
Q3 | $166K | Sell |
5,230
-3,439
| -40% | -$109K | ﹤0.01% | 2990 |
|
2023
Q2 | $713K | Buy |
8,669
+4,681
| +117% | +$385K | ﹤0.01% | 2465 |
|
2023
Q1 | $410K | Hold |
3,988
| – | – | ﹤0.01% | 2651 |
|
2022
Q4 | $584K | Hold |
3,988
| – | – | ﹤0.01% | 2545 |
|
2022
Q3 | $674K | Buy |
3,988
+392
| +11% | +$66.3K | ﹤0.01% | 2496 |
|
2022
Q2 | $415K | Buy |
3,596
+504
| +16% | +$58.2K | ﹤0.01% | 2751 |
|
2022
Q1 | $308K | Buy |
3,092
+8
| +0.3% | +$797 | ﹤0.01% | 2852 |
|
2021
Q4 | $480K | Buy |
3,084
+204
| +7% | +$31.8K | ﹤0.01% | 2754 |
|
2021
Q3 | $679K | Hold |
2,880
| – | – | ﹤0.01% | 2632 |
|
2021
Q2 | $978K | Hold |
2,880
| – | – | ﹤0.01% | 2532 |
|
2021
Q1 | $1.17M | Sell |
2,880
-252
| -8% | -$102K | ﹤0.01% | 2331 |
|
2020
Q4 | $2.08M | Hold |
3,132
| – | – | ﹤0.01% | 1946 |
|
2020
Q3 | $1.46M | Buy |
3,132
+40
| +1% | +$18.6K | ﹤0.01% | 2008 |
|
2020
Q2 | $1.81M | Buy |
3,092
+1,532
| +98% | +$896K | ﹤0.01% | 1888 |
|
2020
Q1 | $227K | Buy |
1,560
+1,036
| +198% | +$151K | ﹤0.01% | 2738 |
|
2019
Q4 | $75K | Hold |
524
| – | – | ﹤0.01% | 3060 |
|
2019
Q3 | $21K | Hold |
524
| – | – | ﹤0.01% | 3137 |
|
2019
Q2 | $53K | Buy |
+524
| New | +$53K | ﹤0.01% | 3121 |
|
2018
Q3 | – | Sell |
-2,316
| Closed | -$1.03M | – | 3138 |
|
2018
Q2 | $1.03M | Buy |
+2,316
| New | +$1.03M | ﹤0.01% | 2293 |
|